Get started
BLUEBIRD BIO INC COM USD0.01 (REV SPT)BLUEBIRD BIO INC COM USD0.01 (REV SPT)BLUEBIRD BIO INC COM USD0.01 (REV SPT)

BLUEBIRD BIO INC COM USD0.01 (REV SPT)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0HOH chart


Full chart

0HOH upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪43.76 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−24.8555 USD
Net income (FY)
‪−240.72 M‬ USD
Revenue (FY)
‪83.81 M‬ USD
Shares float
‪9.68 M‬
Beta (1Y)
−0.19

Employees


Employees (FY)
248
Change (1Y)
−127 −33.87%
Revenue / Employee (1Y)
‪337.93 K‬ USD
Net income / Employee (1Y)
‪−970.63 K‬ USD

About bluebird bio, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Andrew Obenshain
Website
bluebirdbio.com
Headquarters
Somerville
Founded
1992
FIGI
BBG00JVJSPQ8
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0HOH news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 0HOH.

Frequently Asked Questions


The current price of 0HOH is 3.9000 USD — it hasn't changed in the past 24 hours. Watch BLUEBIRD BIO INC COM USD0.01 (REV SPT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BLUEBIRD BIO INC COM USD0.01 (REV SPT) stocks are traded under the ticker 0HOH.
We've gathered analysts' opinions on BLUEBIRD BIO INC COM USD0.01 (REV SPT) future price: according to them, 0HOH price has a max estimate of 8.00 USD and a min estimate of 5.00 USD. Watch 0HOH chart and read a more detailed BLUEBIRD BIO INC COM USD0.01 (REV SPT) stock forecast: see what analysts think of BLUEBIRD BIO INC COM USD0.01 (REV SPT) and suggest that you do with its stocks.
0HOH reached its all-time high on Mar 13, 2018 with the price of 2,515.5605 USD, and its all-time low was 3.9000 USD and was reached on Mar 4, 2025. View more price dynamics on 0HOH chart.
See other stocks reaching their highest and lowest prices.
0HOH stock is 0.00% volatile and has beta coefficient of −0.19. Track BLUEBIRD BIO INC COM USD0.01 (REV SPT) stock price on the chart and check out the list of the most volatile stocks — is BLUEBIRD BIO INC COM USD0.01 (REV SPT) there?
Today BLUEBIRD BIO INC COM USD0.01 (REV SPT) has the market capitalization of ‪43.76 M‬, it has increased by 3.09% over the last week.
Yes, you can track BLUEBIRD BIO INC COM USD0.01 (REV SPT) financials in yearly and quarterly reports right on TradingView.
BLUEBIRD BIO INC COM USD0.01 (REV SPT) is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
0HOH earnings for the last quarter are −4.75 USD per share, whereas the estimation was −6.15 USD resulting in a 22.75% surprise. The estimated earnings for the next quarter are −3.29 USD per share. See more details about BLUEBIRD BIO INC COM USD0.01 (REV SPT) earnings.
BLUEBIRD BIO INC COM USD0.01 (REV SPT) revenue for the last quarter amounts to ‪25.25 M‬ USD, despite the estimated figure of ‪27.20 M‬ USD. In the next quarter, revenue is expected to reach ‪38.74 M‬ USD.
0HOH net income for the last quarter is ‪−28.71 M‬ USD, while the quarter before that showed ‪−60.81 M‬ USD of net income which accounts for 52.78% change. Track more BLUEBIRD BIO INC COM USD0.01 (REV SPT) financial stats to get the full picture.
No, 0HOH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 17, 2025, the company has 248 employees. See our rating of the largest employees — is BLUEBIRD BIO INC COM USD0.01 (REV SPT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BLUEBIRD BIO INC COM USD0.01 (REV SPT) EBITDA is ‪−206.46 M‬ USD, and current EBITDA margin is −246.35%. See more stats in BLUEBIRD BIO INC COM USD0.01 (REV SPT) financial statements.
Like other stocks, 0HOH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BLUEBIRD BIO INC COM USD0.01 (REV SPT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BLUEBIRD BIO INC COM USD0.01 (REV SPT) technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BLUEBIRD BIO INC COM USD0.01 (REV SPT) stock shows the sell signal. See more of BLUEBIRD BIO INC COM USD0.01 (REV SPT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.